A detailed history of Amundi transactions in Insmed Inc stock. As of the latest transaction made, Amundi holds 42 shares of INSM stock, worth $3,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Holding current value
$3,281
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$66.29 - $76.63 $2,784 - $3,218
42 New
42 $2,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $54,835 - $70,847
-2,118 Reduced 30.1%
4,918 $116,000
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $170,060 - $253,366
7,036 New
7,036 $200,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.